CAM
BRLI

Capstone Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Capstone Asset Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,593
Closed -$313K – 1638
2015
Q2 		$313K Sell
7,593
-3,650
-32% -$131K 0.01% 1274
2015
Q1 		$396K Buy
11,243
+570
+5% +$19.3K 0.01% 1235
2014
Q4 		$343K Sell
10,673
-1,310
-11% -$37.9K 0.01% 1296
2014
Q3 		$336K Sell
11,983
-150
-1% -$4.57K 0.01% 1286
2014
Q2 		$367K Buy
12,133
+1,434
+13% +$39.6K 0.01% 1266
2014
Q1 		$296K Sell
10,699
-690
-6% -$18.1K 0.01% 1429
2013
Q4 		$291K Sell
11,389
-6,677
-37% -$206K 0.01% 1537
2013
Q3 		$540K Buy
18,066
+260
+1% +$7.23K 0.01% 1227
2013
Q2 		$512K Buy
+17,806
New +$491K 0.01% 1183

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Capstone Asset Management's BRLI Position: Q3 2015 in Review

Capstone Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 7,593 shares — an estimated $313K sold.

Capstone Asset Management first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $540K in Q3 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Capstone Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Capstone Asset Management sold 7,593 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $313K.
  • Capstone Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Capstone Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $540K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Capstone Asset Management's 13F filing for Q3 2015, filed 20 Oct 2015.